Three-dimensional cultured tissue constructs that imitate human living tissue organization for analysis of tumor cell invasion.
human oral epithelial tissue
oral squamous cell carcinoma (OSCC) cells
three-dimensional (3D) cultured tissue constructs
tissue engineering
tumor cell invasion
Journal
Journal of biomedical materials research. Part A
ISSN: 1552-4965
Titre abrégé: J Biomed Mater Res A
Pays: United States
ID NLM: 101234237
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
22
09
2017
revised:
09
12
2017
accepted:
21
12
2017
pubmed:
28
12
2017
medline:
29
5
2020
entrez:
28
12
2017
Statut:
ppublish
Résumé
Preventing cancer metastasis requires a thorough understanding of cancer cell invasion. These phenomena occur in human 3-D living tissues. To this end, we developed a human cell-based three-dimensional (3-D) cultured tissue constructs that imitate in vivo human tissue organization. We investigated whether our 3-D cell culture system can be used to analyze the invasion of human oral squamous cell carcinoma (OSCC) cells. The 3-D tissue structure consisted of five layers of normal human dermal fibroblasts along with human dermal lymphatic endothelial cell tubes and was generated by the cell accumulation technique and layer-by-layer assembly using fibronectin and gelatin. OSCC cells with different lymph metastatic capacity were inoculated on the 3-D tissues and their invasion through the 3-D tissue structure was observed. Conventional methods of analyzing cell migration and invasion, that is, 2-D culture-based transwell and Matrigel assays were also used for comparison. The results using the 3-D cultured tissue constructs were comparable to those obtained using conventional assays; moreover, use of the 3-D system enabled visualization of differential invasion capacities of cancer cells. These results indicate that our 3-D cultured tissue constructs can be a useful tool for analysis of cancer cell invasion in a setting that reflects the in vivo tissue organization. © 2018 The Authors. Journal of Biomedical Materials Research Part A published by Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 292-300, 2019.
Identifiants
pubmed: 29280265
doi: 10.1002/jbm.a.36319
pmc: PMC6587574
doi:
Substances chimiques
Biocompatible Materials
0
Fibronectins
0
Gelatin
9000-70-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
292-300Informations de copyright
© 2018 The Authors. Journal of Biomedical Materials Research Part A published by Wiley Periodicals, Inc.
Références
Oncogene. 2015 Aug 20;34(34):4531-44
pubmed: 25486435
Biochem Biophys Res Commun. 2010 Nov 5;402(1):153-7
pubmed: 20933501
Nature. 2006 May 25;441(7092):451-6
pubmed: 16724057
Gastroenterology. 2008 Jun;134(7):1981-93
pubmed: 18439605
Adv Mater. 2011 Aug 16;23(31):3506-10
pubmed: 21728193
J Biomed Mater Res. 1999 Jun 15;45(4):355-62
pubmed: 10321708
Int J Oncol. 2012 Sep;41(3):885-92
pubmed: 22735610
J Vis Exp. 2015 Nov 20;(105):
pubmed: 26649463
Nat Protoc. 2009;4(3):309-24
pubmed: 19214182
Nat Rev Cancer. 2009 Apr;9(4):239-52
pubmed: 19279573
J Biomater Sci Polym Ed. 2012;23(1-4):63-79
pubmed: 21176392
Nat Rev Cancer. 2002 Mar;2(3):161-74
pubmed: 11990853
Clin Exp Metastasis. 2015 Oct;32(7):739-53
pubmed: 26319373
J Vis Exp. 2014 Jun 11;(88):
pubmed: 24961804
Mol Oncol. 2007 Jun;1(1):84-96
pubmed: 18516279
Acta Biomater. 2016 Mar;33:110-21
pubmed: 26821339
Nat Med. 2011 Nov 07;17(11):1359-70
pubmed: 22064426
Angew Chem Int Ed Engl. 2007;46(25):4689-92
pubmed: 17503408
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271600
Expert Opin Drug Deliv. 2009 Nov;6(11):1207-17
pubmed: 19831583
J Biomed Mater Res A. 2019 Feb;107(2):292-300
pubmed: 29280265
Int J Oncol. 2014 Jan;44(1):59-68
pubmed: 24220306
Biomaterials. 2010 Mar;31(7):1646-54
pubmed: 19962187
Nat Mater. 2016 Feb;15(2):227-34
pubmed: 26595121
Biomaterials. 2010 May;31(14):3903-9
pubmed: 20170957
Nat Med. 2006 Aug;12(8):895-904
pubmed: 16892035